237 related articles for article (PubMed ID: 2550511)
21. Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor.
Tanaka M; Yano S; Hasegawa Y; Nakao K
Arzneimittelforschung; 1994 Jun; 44(6):774-8. PubMed ID: 8053980
[TBL] [Abstract][Full Text] [Related]
22. Effects of etomidate on cortisol biosynthesis in isolated guinea-pig adrenal cells: comparison with metyrapone.
De Coster R; Beerens D; Haelterman C; Wouters L
J Endocrinol Invest; 1985 Jun; 8(3):199-202. PubMed ID: 2993407
[TBL] [Abstract][Full Text] [Related]
23. Basal and ACTH-stimulated cortisol and aldosterone release from adrenocortical adenomas in vitro.
Gröndal S; Grimelius L; Thorén M; Hamberger B
Eur J Surg; 1991 Mar; 157(3):179-83. PubMed ID: 1678626
[TBL] [Abstract][Full Text] [Related]
24. Effects of Fadrozole (CGS 16949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patients.
Demers LM
Breast Cancer Res Treat; 1994; 30(1):95-102. PubMed ID: 7949208
[TBL] [Abstract][Full Text] [Related]
25. ACTH sensitivity of isolated human pathological adrenocortical cells: variability of responses in aldosterone, corticosterone, deoxycorticosterone and cortisol production.
Rácz K; Varga I; Kiss R; Gláz E
J Steroid Biochem; 1984 May; 20(5):1187-94. PubMed ID: 6328122
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of bovine adrenocortical steroidogenesis by benzodiazepines: a direct effect on microsomal hydroxylation or an inhibition of calcium uptake?
Thomson I; Fraser R; Kenyon CJ
J Endocrinol; 1992 Nov; 135(2):361-9. PubMed ID: 1335473
[TBL] [Abstract][Full Text] [Related]
27. Proadrenomedullin N-terminal 20 peptide inhibits aldosterone secretion of human adrenocortical and Conn's adenoma cells: comparison with adrenomedullin effect.
Andreis PG; Tortorella C; Mazzocchi G; Nussdorfer GG
J Clin Endocrinol Metab; 1998 Jan; 83(1):253-7. PubMed ID: 9435451
[TBL] [Abstract][Full Text] [Related]
28. In vitro potency and selectivity of the non-steroidal androgen aromatase inhibitor CGS 16949A compared to steroidal inhibitors in the brain.
Wozniak A; Holman SD; Hutchison JB
J Steroid Biochem Mol Biol; 1992 Oct; 43(4):281-7. PubMed ID: 1390279
[TBL] [Abstract][Full Text] [Related]
29. Inhibition by etomidate of steroidogenesis in isolated bovine adrenal cells.
Kenyon CJ; Young J; Gray CE; Fraser R
J Clin Endocrinol Metab; 1984 May; 58(5):947-9. PubMed ID: 6323520
[TBL] [Abstract][Full Text] [Related]
30. Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats.
Iino Y; Sugamata N; Owada S; Tago T; Sato H; Yokoe T; Maemura M; Morishita Y; Horiuchi R
Jpn J Clin Oncol; 1991 Jun; 21(3):153-9. PubMed ID: 1834875
[TBL] [Abstract][Full Text] [Related]
31. Reversible inhibition of human placental microsomal aromatase by CGS 18320B and other non-steroidal compounds.
Bullion KA; Osawa Y; Braun DG
Endocr Res; 1990; 16(2):255-67. PubMed ID: 2140551
[TBL] [Abstract][Full Text] [Related]
32. Clinical use of aromatase inhibitors in human breast carcinoma.
Santen RJ
J Steroid Biochem Mol Biol; 1991; 40(1-3):247-53. PubMed ID: 1835644
[TBL] [Abstract][Full Text] [Related]
33. Cortisol production by aldosterone-producing adenomas in vitro.
Stowasser M; Tunny TJ; Klemm SA; Gordon RD
Clin Exp Pharmacol Physiol; 1993 May; 20(5):292-5. PubMed ID: 8391943
[TBL] [Abstract][Full Text] [Related]
34. Aminoglutethimide and ketoconazole: historical perspectives and future prospects.
Shaw MA; Nicholls PJ; Smith HJ
J Steroid Biochem; 1988 Jul; 31(1):137-46. PubMed ID: 2969435
[TBL] [Abstract][Full Text] [Related]
35. Open dose-finding study of a new potent and selective nonsteroidal aromatase inhibitor, CGS 20 267, in healthy male subjects.
Trunet PF; Mueller P; Bhatnagar AS; Dickes I; Monnet G; White G
J Clin Endocrinol Metab; 1993 Aug; 77(2):319-23. PubMed ID: 8345034
[TBL] [Abstract][Full Text] [Related]
36. Aromatase inhibition in the dog. II. Effect on growth, function, and pathology of the prostate.
Oesterling JE; Juniewicz PE; Walters JR; Strandberg JD; Steele RE; Ewing LL; Coffey DS
J Urol; 1988 Apr; 139(4):832-9. PubMed ID: 2451040
[TBL] [Abstract][Full Text] [Related]
37. Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women.
Iveson TJ; Smith IE; Ahern J; Smithers DA; Trunet PF; Dowsett M
J Clin Endocrinol Metab; 1993 Aug; 77(2):324-31. PubMed ID: 8345035
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the potential of polyphenols as a CYP17 inhibitor free of adverse corticosteroid elevation.
Lin CJ; Cheng LC; Lin TC; Wang CJ; Li LA
Biochem Pharmacol; 2014 Aug; 90(3):288-96. PubMed ID: 24875446
[TBL] [Abstract][Full Text] [Related]
39. Recent progress in development of aromatase inhibitors.
Santen RJ
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1029-35. PubMed ID: 2149503
[TBL] [Abstract][Full Text] [Related]
40. Short-term kinetics of serum adrenal steroids and plasma ACTH after a single dose of metyrapone in man.
Schöneshöfer M; Schefzig B; Arabin S
J Endocrinol Invest; 1980; 3(3):229-36. PubMed ID: 6253555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
